These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22028097)

  • 1. Noninvasive prenatal diagnosis: pregnant women's interest and expected uptake.
    Tischler R; Hudgins L; Blumenfeld YJ; Greely HT; Ormond KE
    Prenat Diagn; 2011 Dec; 31(13):1292-9. PubMed ID: 22028097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient preferences for prenatal testing of microdeletion and microduplication syndromes.
    Calonico E; Blumenfeld YJ; Hudgins L; Taylor J
    Prenat Diagn; 2016 Mar; 36(3):244-51. PubMed ID: 26687911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of knowledge, education, and experience on acceptance of first trimester screening for chromosomal anomalies.
    Stefansdottir V; Skirton H; Jonasson K; Hardardottir H; Jonsson JJ
    Acta Obstet Gynecol Scand; 2010 Jul; 89(7):931-8. PubMed ID: 20235896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive prenatal diagnosis for single gene disorders: experience of patients.
    Lewis C; Hill M; Chitty LS
    Clin Genet; 2014 Apr; 85(4):336-42. PubMed ID: 23631435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical considerations for choosing between possible models for using NIPD for aneuploidy detection.
    Deans Z; Newson AJ
    J Med Ethics; 2012 Oct; 38(10):614-8. PubMed ID: 22745108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal age-based prenatal screening for chromosomal disorders: attitudes of women and health care providers toward changes.
    Carroll JC; Rideout A; Wilson BJ; Allanson J; Blaine S; Esplen MJ; Farrell S; Graham GE; MacKenzie J; Meschino WS; Prakash P; Shuman C; Taylor S; Tobin S
    Can Fam Physician; 2013 Jan; 59(1):e39-47. PubMed ID: 23341678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes toward non-invasive prenatal diagnosis among pregnant women and health professionals in Japan.
    Yotsumoto J; Sekizawa A; Koide K; Purwosunu Y; Ichizuka K; Matsuoka R; Kawame H; Okai T
    Prenat Diagn; 2012 Jul; 32(7):674-9. PubMed ID: 22553071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women's views and the impact of noninvasive prenatal testing on procedures in a managed care setting.
    Tiller GE; Kershberg HB; Goff J; Coffeen C; Liao W; Sehnert AJ
    Prenat Diagn; 2015 May; 35(5):428-33. PubMed ID: 25201151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive prenatal testing for fetal aneuploidy and single gene disorders.
    Skrzypek H; Hui L
    Best Pract Res Clin Obstet Gynaecol; 2017 Jul; 42():26-38. PubMed ID: 28342726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new fetal RHD genotyping test: costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales.
    Szczepura A; Osipenko L; Freeman K
    BMC Pregnancy Childbirth; 2011 Jan; 11():5. PubMed ID: 21244652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing Group Prenatal Counseling for Expanded Noninvasive Screening Options.
    Gammon BL; Otto L; Wick M; Borowski K; Allyse M
    J Genet Couns; 2018 Aug; 27(4):894-901. PubMed ID: 29247311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Will the introduction of non-invasive prenatal diagnostic testing erode informed choices? An experimental study of health care professionals.
    van den Heuvel A; Chitty L; Dormandy E; Newson A; Deans Z; Attwood S; Haynes S; Marteau TM
    Patient Educ Couns; 2010 Jan; 78(1):24-8. PubMed ID: 19560305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosocial correlates of pregnant women's attitudes toward prenatal maternal serum screening and invasive diagnostic testing: beyond traditional risk status.
    Lumley MA; Zamerowski ST; Jackson L; Dukes K; Sullivan L
    Genet Test; 2006; 10(2):131-8. PubMed ID: 16792517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facilitating autonomous, confident and satisfying choices: a mixed-method study of women's choice-making in prenatal screening for common aneuploidies.
    Chen A; Tenhunen H; Torkki P; Peltokorpi A; Heinonen S; Lillrank P; Stefanovic V
    BMC Pregnancy Childbirth; 2018 May; 18(1):119. PubMed ID: 29720125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Client views and attitudes to non-invasive prenatal diagnosis for sickle cell disease, thalassaemia and cystic fibrosis.
    Hill M; Compton C; Karunaratna M; Lewis C; Chitty L
    J Genet Couns; 2014 Dec; 23(6):1012-21. PubMed ID: 24788196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does offering prenatal screening influence pregnant women's attitudes regarding prenatal testing?
    Kleinveld JH; van den Berg M; van Eijk JT; van Vugt JM; van der Wal G; Timmermans DR
    Community Genet; 2008; 11(6):368-74. PubMed ID: 18690005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive prenatal genetic testing: a study of public attitudes.
    Kelly SE; Farrimond HR
    Public Health Genomics; 2012; 15(2):73-81. PubMed ID: 22094262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the Human Genome Initiative on women's rights and reproductive decisions.
    Charo RA
    Fetal Diagn Ther; 1993 Apr; 8(Suppl. 1):148-59. PubMed ID: 11653014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal diagnosis: choices women make about pursuing testing and acting on abnormal results.
    Pryde PG; Drugan A; Johnson MP; Isada NB; Evans MI
    Clin Obstet Gynecol; 1993 Sep; 36(3):496-509. PubMed ID: 8403601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.